Tailoring Basal Bolus Therapy for T2D Patients

Introduction

Take This Event

In this lecture,Dr. Nasser Al Juhani will explain the importance of early and timely glycemic control for patients with T2D while highlighting on how biosimilars are developed and how they work for the patient characteristic that will benefit from adding rapid acting insulin to their regimen.

Objectives

• Understanding the importance of early and timely glycemic control for patients with diabetes.
• Understanding how biosimilars are developed and how they work.
• Identify patient characteristics most appropriate to add rapid acting insulin to their regimen.

See Registration Policies, Cancellations & Refunds